MetLife Investment Advisors »

Theravance Biopharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $333k 30k 11.24
2023-09-30 $293k 34k 8.63
2023-06-30 $351k 34k 10.35
2022-12-31 $381k 34k 11.22
2022-09-30 $344k 34k 10.14
2022-06-30 $308k 34k 9.06
2022-03-31 $325k 34k 9.56
2021-12-31 $242k 22k 11.05
2021-09-30 $49k 6.6k 7.40
2021-03-31 $378k 19k 20.41
2020-12-31 $378k 21k 17.77
2020-09-30 $314k 21k 14.79
2020-06-30 $446k 21k 20.99
2020-03-31 $491k 21k 23.11
2019-12-31 $510k 20k 25.89
2019-09-30 $384k 20k 19.48
2019-06-30 $322k 20k 16.33
2019-03-31 $446k 20k 22.67
2018-12-31 $504k 20k 25.59
2018-09-30 $643k 20k 32.67